[Federal Register Volume 66, Number 34 (Tuesday, February 20, 2001)]
[Notices]
[Pages 10896-10897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-4085]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Minority Institutions' Drug Abuse Research 
Development Program.
    Date: March 23, 2001.
    Time: 2 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Marina L. Volkov, PhD, Health Scientist 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, National Institutes

[[Page 10897]]

of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, 
Bethesda, MD 20892-9547, (301) 435-1433.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: February 12, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-4085 Filed 2-16-01; 8:45 am]
BILLING CODE 4140-01-M